References - iarc

More documents

Recommendations

Info

2686. Silverberg SG (1999). Protocol for the examination of specimens from patients with carcinomas of the endometrium: a basis for checklists. Cancer Committee, College of American Pathologists. Arch Pathol Lab Med 123: 28-32. 2687. Silverberg SG (2000). Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol 19: 7-15. 2688. Silverberg SG (2000). Problems in the differential diagnosis of endometrial hyperplasia and carcinoma. Mod Pathol 13: 309-327. 2689. Silverberg SG, Chitale AR (1973). Assessment of significance of proportions of intraductal and infiltrating tumor growth in ductal carcinoma of the breast. Cancer 32: 830-837. 2690. Silverberg SG, Kay S, Koss LG (1971). Postmastectomy lymphangiosarcoma: ultrastructural observations. Cancer 27: 100-108. 2691. Silverberg SG, Kurman RJ (1992). Atlas of Tumour Pathology. Tumours of the uterine corpus and gestational trophoblastic disease, AFIP: Washington DC. 2692. Silverberg SG, Major FJ, Blessing JA, Fetter B, Askin FB, Liao SY, Miller A (1990). Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol 9: 1-19. 2693. Silverberg SG, Willson MA, Board JA (1971). Hemangiopericytoma of the uterus: an ultrastructural study. Am J Obstet Gynecol 110: 397-404. 2694. Silverman EM, Oberman HA (1974). Metastatic neoplasms in the breast. Surg Gynecol Obstet 138: 26-28. 2695. Silverstein MJ, Gierson ED, Colburn WJ, Rosser RJ, Waisman JR, Gamagami P (1991). Axillary lymphadenectomy for intraductal carcinoma of the breast. S u r g Gynecol Obstet 172: 211-214. 2696. Silverstein MJ, Lewinsky BS, Waisman JR, Gierson ED, Colburn WJ, Senofsky GM, Gamagami P (1994). Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 73: 1673-1677. 2697. Simkin PH, Ramirez LA, Zweizig SL, Afonso SA, Fraire AE, Khan A, Dunn AD, Dunn JT, Braverman LE (1999). Monomorphic teratoma of the ovary: a rare cause of triiodothyronine toxicosis. Thyroid 9: 949-954. 2698. Simpson JF, Page DL, Dupont WD (1990). Apocrine adenosis - a mimmic of mammary carcinoma. Surgical Pathology 3: 289-299. 2699. Simpson JF, Page DL, Dupont WD (1990). Apocrine adenosis - an occasional mimicker of breast carcinoma. Mod Pathol 3. 2700. Simpson JF, Quan DE, O'Malley F, Odom-Maryon T, Clarke PE (1997). Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. Am J Pathol 151: 161-168. 2701. Simpson JL, Michael H, Roth LM (1998). Unclassified sex cord-stromal tumors of the ovary: a report of eight cases. Arch Pathol Lab Med 122: 52-55. 2702. Simpson RH, Cope N, Skalova A, Michal M (1998). Malignant adenomyoepithelioma of the breast with mixed osteogenic, spindle cell, and carcinomatous differentiation. Am J Surg Pathol 22: 631-636. 2703. Simpson T, Thirlby RC, Dail DH (1992). Surgical treatment of ductal carcinoma in situ of the breast. 10- to 20-year follow-up. Arch Surg 127: 468-472. 2704. Simsek T, Trak B, Tunc M, Karaveli S, Uner M, Sonmez C (1998). Primary pure choriocarcinoma of the ovary in reproduc - tive ages: a case report. Eur J Gynaecol Oncol 19: 284-286. 2705. Singer A, Monaghan J (2000). Lower Genital Tract Precancer. Colposcopy, Pathology and Treatment. 2nd ed. Blackwell Science Ltd: Oxford. 2706. Singer G, Kurman RJ, Chang HW, Cho SK, Shih I (2002). Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol 160: 1223-1228. 2707. Singer G, Oldt R, III, Cohen Y, Wang BG, Sidransky D, Kurman RJ, Shih I (2003). Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 95: 484-486. 2708. Singh TT, Hopkins MP, Price J, Schuen R (1992). Myxoid liposarcoma of the broad ligament. Int J Gynecol Cancer 2: 220-223. 2709. Singhal S, Sharma S, De S, Kumar L, Chander S, Rath GK, Gupta SD (1990). Adult embryonal rhabdomyosarcoma of the vagina complicating pregnancy: a case report and review of the literature. Asia Oceania J Obstet Gynaecol 16: 301-306. 2710. Sinkre P, Albores-Saavedra J, Miller DS, Copeland LJ, Hameed A (2000). Endometrial endometrioid carcinomas associated with Ewing sarcoma/peripheral primitive neuroectodermal tumor. Int J Gynecol Pathol 19: 127-132. 2711. Sinkre P, Miller DS, Milchgrub S, Hameed A (2000). Adenomyofibroma of the endometrium with skeletal muscle differentiation. Int J Gynecol Pathol 19: 280-283. 2712. Sinniah R, O'Brien FV (1973). Pigmented progonoma in a dermoid cyst of the ovary. J Pathol 109: 357-359. 2713. Siriaunkgul S, Robbins KM, McGowan L, Silverberg SG (1995). Ovarian mucinous tumors of low malignant potential: a clinicopathologic study of 54 tumors of intestinal and mullerian type. Int J Gynecol Pathol 14: 198-208. 2714. Sirota RL, Dickersin GR, Scully RE (1981). Mixed tumors of the vagina. A clini - copathological analysis of eight cases.Am J Surg Pathol 5: 413-422. 2715. Sit AS, Price FV, Kelley JL, Comerci JT, Kunschner AJ, Kanbour-Shakir A, Edwards RP (2000). Chemotherapy for malignant mixed Mullerian tumors of the ovary. Gynecol Oncol 79: 196-200. 2 7 1 6 . Sjostedt S, Whalen T (1961). Prognosis of granulosa cell tumours. Acta Obstet Gynecol Scand 40(suppl 6): 3-26. 2717. Skelton H, Smith KJ (2001). Spindle cell epithelioma of the vagina shows immunohistochemical staining supporting its origin from a primitive/progenitor cell population. Arch Pathol Lab Med 125: 547- 550. 2718. Skinnider BF, Clement PB, MacPherson N, Gascoyne RD, Viswanatha DS (1999). Primary non-Hodgkin's lymphoma and malakoplakia of the vagina: a case report. Hum Pathol 30: 871-874. 2719. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 2 3 5 : 177-182. 2720. Slanetz PJ, Whitman GJ, Halpern EF, Hall DA, McCarthy KA, Simeone JF (1997). Imaging of fallopian tube tumors. AJR Am J Roentgenol 169: 1321-1324. 2720a. Slattery ML, Kerber RA (1993). A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database. JAMA 270: 1563- 1568. 2721. Sloan D (1988). Diagnosis of a tumor with an unusual presentation in the pelvis. Am J Obstet Gynecol 159: 826-827. 2722. Sloane JP (2001). Biopsy Pathology of the Breast. 2nd ed. Arnold: London. 2723. Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Bussolati G, Coleman D, Connolly CE, Dervan P, Eusebi V, De Miguel C, Drijkoningen M, Elston CW, Faverley D, Gad A, Jacquemier J, Lacerda M, Martinez-Penuela J, Munt C, Peterse JL, Rank F, Sylvan M, Tsakraklides V, Zafrani B (1998). Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology. Hum Pathol 29: 1056- 1062. 2724. Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Bussolati G, Coleman D, Connolly CE, Eusebi V, De Miguel C, Dervan P, Drijkoningen R, Elston CW, Faverly D, Gad A, Jacquemier J, Lacerda M, Martinez-Penuela J, Munt C, Peterse JL, Rank F, Sylvan M, Tsakraklides V, Zafrani B (1999). Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology. Virchows Arch 434: 3-10. 2725. Sloane JP, Mayers MM (1993). Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology 23: 225-231. 2726. Sloboda J, Zaviacic M, Jakubovsky J, Hammar E, Johnsen J (1998). Metastasizing adenocarcinoma of the female prostate (Skene's paraurethral glands). Histological and immunohistochemical prostate markers studies and first ultrastructural observation. P a t h o l Res Pract 194: 129-136. 2727. Slomovitz BM, Caputo TA, Gretz HF, III, Economos K, Tortoriello DV, Schlosshauer PW, Baergen RN, Isacson C, Soslow RA (2002). A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary com - ponent. Am J Surg Pathol 26: 592-600. 2728. Smit VT, Cornelisse CJ, De Jong D, Dijkshoorn NJ, Peters AA, Fleuren GJ (1988). Analysis of tumor heterogeneity in a patient with synchronously occurring female genital tract malignancies by DNA flow cytometry, DNA fingerprinting, and immunohistochemistry. Cancer 62: 1146- 1152. 2 7 2 9 . Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt PA, Folsom AR, Goldbohm RA, Graham S, Holmberg L, Howe GR, Marshall JR, Miller AB, Potter JD, Speizer FE, Willett WC, Wolk A, Hunter DJ (1998). Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA 279: 535-540. 2 7 3 0 . Smith BH, Taylor HB (1969). The occurrence of bone and cartilage in mammary tumors. Am J Clin Pathol 51: 610-618. 2 7 3 1 . Smith DR, Ji CY, Goh HS (1996). Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br J Cancer 74: 216-223. 2732. Smith HO, Qualls CR, Romero AR, Webb JC, Dorin MH, Padilla LA, Key CR (2002). Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix? Gynec Oncol 85: 229-241. 2733. Smith J, Munoz N, Herrero R, Eluf- Neto J, Ngelangel C, Franceschi S, Bosch FX, Walboomers JM, Peeling RW (2002). Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 185: 324- 331. 2734. Smith JS, Herrero R, Bosetti C, Munoz N, Bosch FX, Eluf-Neto J, Castellsague X, Meijer CJ, van den Brule AJ, Franceschi S, Ashley R (2002). Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 94: 1604-1613. 2735. Smith TM, Lee MK, Szabo CI, Jerome N, McEuen M, Taylor M, Hood L, King MC (1996). Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res 6: 1029- 1049. 2736. Smith YR, Quint EH, Hinton EL (1998). Recurrent benign mullerian papilloma of the cervix. J Pediatr Adolesc Gynecol 11: 29-31. 2737. Snyder RR, Norris HJ, Tavassoli F (1988). Endometrioid proliferative and low malignant potential tumors of the ovary. A clinicopathologic study of 46 cases. Am J Surg Pathol 12: 661-671. 2738. Soares J, Tomasic G, Bucciarelli E, Eusebi V (1994). Intralobular growth of myoepithelial cell carcinoma of the breast. Virchows Arch 425: 205-210. 2739. Sobin LH, Wittekind CH (1997). Breast Tumours in TNM. 5th ed. Wiley-Liss: New York. 2740. Sodha N, Houlston RS, Bullock SL, Yuille MA, Chu C, Turner G, Eeles RA (2002). Increasing evidence that germline mutations in CHEK2 do not cause Li- Fraumeni syndrome. Hum Mutat 20: 460- 462. 2741. Sodha N, Houlston RS, Williams R, Yuille MA, Mangion J, Eeles RA (2002). A robust method for detecting CHK2/RAD53 mutations in genomic DNA. Hum Mutat 19: 173-177. 2742. Sodha N, Williams R, Mangion J, Bullock SL, Yuille MR, Eeles RA (2000). Screening hCHK2 for mutations. Science 289: 359. 2743. Soga J, Osaka M, Yakuwa Y (2000). Carcinoids of the ovary: an analysis of 329 reported cases. J Exp Clin Cancer Res 19: 271-280. 2 7 4 4 . Solin LJ, Fowble BL, Yeh IT, Kowalyshyn MJ, Schultz DJ, Weiss MC, Goodman RL (1992). Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 23: 961-968. 2745. Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Zhang H, Wu GS, Licht JD, Weber BL, El Deiry WS (1997). Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 389: 187-190. <strong>References</strong> 415
2746. Somerville JE, Clarke LA, Biggart JD (1992). c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma. J Clin Pathol 45: 16-20. 2747. Sonnendecker HE, Cooper K, Kalian KN (1994). Primary fallopian tube adenocarcinoma in situ associated with adjuvant tamoxifen therapy for breast carcinoma. Gynecol Oncol 52: 402-407. 2748. Sonoda Y, Saigo PE, Federici MG, Boyd J (2000). Carcinosarcoma of the ovary in a patient with a germline BRCA2 mutation: evidence for monoclonal origin. Gynecol Oncol 76: 226-229. 2749. Sood AK, Sorosky JI, Gelder MS, Buller RE, Anderson B, Wilkinson EJ, Benda JA, Morgan LS (1998). Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction. Cancer 82: 1731-1737. 2 7 5 0 . Soomro S, Shousha S, Taylor P, Shepard HM, Feldmann M (1991). c-erbB-2 expression in different histological types of invasive breast carcinoma. J Clin Pathol 44: 211-214. 2751. Sorbe B, Risberg B, Thornthwaite J (1994). Nuclear morphometry and DNA flow cytometry as prognostic methods for endometrial carcinoma. Int J Gynecol Cancer 4: 94-100. 2752. Sordillo PP, Chapman R, Hajdu SI, Magill GB, Golbey RB (1981). Lymphangiosarcoma. Cancer 48: 1674-1679. 2753. Soreide JA, Anda O, Eriksen L, Holter J, Kjellevold KH (1988). Pleomorphic adenoma of the human breast with local recurrence. Cancer 61: 997-1001. 2754. Sorensen FB, Paulsen SM (1987). Glycogen-rich clear cell carcinoma of the breast: a solid variant with mucus. A light microscopic, immunohistochemical and ultrastructural study of a case. Histopathology 11: 857-869. 2755. Sorensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjaer L, Linet M, Trichopoulos D, Vilstrup H, Olsen J (1998). Risk of breast cancer in men with liver cir - rhosis. Am J Gastroenterol 93: 231-233. 2756. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein LP, Borresen-Dale AL (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869-10874. 2757. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL, Botstein D (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100: 8418-8423. 2758. Soslow RA, Rouse RV, Hendrickson MR, Silva EG, Longacre TA (1996). Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis. Int J Gynecol Pathol 15: 257-265. 2759. Soussi T (1996). The p53 tumour suppressor gene: a model for molecular epidemiology of human cancer. Mol Med Today 2: 32-37. 2760. Soussi T, Beroud C (2001). Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 1: 233- 240. 416 <strong>References</strong> 2761. Soussi T, Dehouche K, Beroud C (2000). p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis. Hum Mutat 15: 105-113. 2762. Spagnolo DV, Shilkin KB (1983). Breast neoplasms containing bone and cartilage. Virchows Arch A Pathol Anat Histopathol 400: 287-295. 2763. Spatz A, Bouron D, Pautier P, Castaigne D, Duvillard P (1998). Primary yolk sac tumor of the endometrium: a case report and review of the literature. Gynecol Oncol 70: 285-288. 2764. Spiegel GW (1995). Endometrial carcinoma in situ in postmenopausal women. Am J Surg Pathol 19: 417-432. 2765. Spitz DJ, Reddy VB, Gattuso P (1999). Fine-needle aspiration of pseudoangioma - tous stromal hyperplasia of the breast. Diagn Cytopathol 20: 323-324. 2766. Spitzer M (1999). Lower genital tract intraepithelial neoplasia in HIV-infected women: guidelines for evaluation and management. Obstet Gynecol Surv 54: 131- 137. 2767. Sreenan JJ, Hart WR (1995). Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis. Am J Surg Pathol 19: 666-674. 2768. Srigley JR, Colgan TJ (1988). Multifocal and diffuse adenomatoid tumor involving uterus and fallopian tube. Ultrastruct Pathol 12: 351-355. 2769. Srivatsa PJ, Keeney GL, Podratz KC (1994). Disseminated cervical adenoma malignum and bilateral ovarian sex cord tumors with annular tubules associated with Peutz-Jeghers syndrome. G y n e c o l Oncol 53: 256-264. 2 7 7 0 . Ssali JC, Gakwaya A, Katongole- Mbidde F (1995). Risk factors for breast cancer in Ugandan women: a case-control study. East Central Afr J Surg 1: 9-13. 2771. Staebler A, Heselmeyer-Haddad K, Bell K, Riopel M, Perlman E, Ried T, Kurman RJ (2002). Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas. Hum Pathol 33: 47- 59. 2772. Staebler A, Lax SF, Ellenson LH (2000). Altered expression of hMLH1 and hMSH2 protein in endometrial carcinomas with microsatellite instability. Hum Pathol 31: 354-358. 2773. Stalsberg H, Blom PE, Bostad LH, Westgaard G (1983). An International Survey of Distributions of Histologic Types of Tumours of the Testis and Ovary (Ovarian tumours and endometriosis in Norway General Hospital material). UICC: Geneva. 2774. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW (1998). Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39. 2775. Stankovic T, Kidd AM, Sutcliffe A, McGuire GM, Robinson P, Weber P, Bedenham T, Bradwell AR, Easton DF, Lennox GG, Haites N, Byrd PJ, Taylor AM (1998). ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 62: 334-345. 2775a. Stapleton JJ, Holser MH, Linder LE (1981). Paramesonephric papillary serous cystadenocarcinoma. A case report with scanning electron microscopy. Acta Cytol 25: 310-316. 2776. Starink TM, van der Veen JP, Arwert F, de Waal LP, de Lange GG, Gille JJ, Eriksson AW (1986). The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet 29: 222-233. 2777. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV (1997). Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362. 2778. Steeper TA, Piscioli F, Rosai J (1983). Squamous cell carcinoma with sarcomalike stroma of the female genital tract. Clinicopathologic study of four cases. Cancer 52: 890-898. 2779. Steeper TA, Rosai J (1983). Aggressive angiomyxoma of the female pelvis and perineum. Report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm. Am J Surg Pathol7: 463-475. 2780. Steeper TA, Wick MR (1986). Minimal deviation adenocarcinoma of the uterine cervix ("adenoma malignum"). An immunohistochemical comparison with microglandular endocervical hyperplasia and conventional endocervical adenocarcinoma. Cancer 58: 1131-1138. 2781. Stefani M, Speranza N (1970). [A case of cylindroma of the vagina]. Riv Anat Patol Oncol 36: 77-105. 2782. Stehman FB, Bundy BN, Disaia PJ, Keys HM, Larson JE, Fowler WC (1991). Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67: 2776-2785. 2783. Stehman FB, Bundy BN, Dvoretsky PM, Creasman WT (1992). Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 79: 490- 497. 2784. Steingaszner LC, Enzinger FM, Taylor HB (1965). Hemangiosarcoma of the breast. Cancer 18: 352-361. 2785. Stenkvist B, Bengtsson E, Dahlqvist B, Eklund G, Eriksson O, Jarkrans T, Nordin B (1982). Predicting breast cancer recurrence. Cancer 50: 2884-2893. 2786. Stenwig JT, Hazekamp JT, Beecham JB (1979). Granulosa cell tumors of the ovary. A clinicopathological study of 118 cases with long-term follow-up. Gynecol Oncol 7: 136-152. 2787. Stephenson TJ, Mills PM (1986). Adenomatoid tumours: an immunohistochemical and ultrastructural appraisal of their histogenesis. J Pathol 148: 327-335. 2788. Sternberg WH, Barclay DL (1966). Luteoma of pregnancy. Am J Obstet Gynecol 95: 165-184. 2789. Sternberg WH, Roth LM (1973). Ovarian stromal tumors containing Leydig cells. I. Stromal-Leydig cell tumor and nonneoplastic transformation of ovarian stroma to Leydig cells. Cancer 32: 940-951. 2790. Stettner AR, Hartenbach EM, Schink JC, Huddart R, Becker J, Pauli R, Long R, Laxova R (1999). Familial ovarian germ cell cancer: report and review. Am J Med Genet 84: 43-46. 2791. Stevens RG (1987). Electric power use and breast cancer: a hypothesis. Am J Epidemiol 125: 556-561. 2792. Stewart CJ, Nandini CL, Richmond JA (2000). Value of A103 (melan-A) immunostaining in the differential diagnosis of ovarian sex cord stromal tumours.J Clin Pathol 53: 206-211. 2793. Stewart FW, Treves N (1949). Lymphangiosarcoma in postmastectomy lymphedema. A report of six cases of elephantiasis chirurgica. Cancer 1: 64-81. 2794. Stock RJ, Zaino R, Bundy BN, Askin FB, Woodward J, Fetter B, Paulson JA, Disaia PJ, Stehman FB (1994). Evaluation and comparison of histopathologic grading systems of epithelial carcinoma of the uterine cervix: Gynecologic Oncology Group studies. Int J Gynecol Pathol 13: 99- 108. 2795. Stocks LH, Patterson FM (1976). Inflammatory carcinoma of the breast. Surg Gynecol Obstet 143: 885-889. 2796. Stomper PC, Connolly JL (1992). Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype. AJR Am J Roentgenol 159: 483-485. 2797. Stone GC, Bell DA, Fuller A, Dickersin GR, Scully RE (1986). Malignant schwannoma of the ovary. Report of a case. Cancer 58: 1575-1582. 2798. Storm HH, Jensen OM (1986). Risk of contralateral breast cancer in Denmark 1943-80. Br J Cancer 54: 483-492. 2799. Storm HH, Olsen J (1999). Risk of breast cancer in offspring of male breastcancer patients. Lancet 353: 209. 2800. Stratton JF, Gayther SA, Russell P, Dearden J, Gore M, Blake P, Easton D, Ponder BA (1997). Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 336: 1125-1130. 2801. Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA (1998). A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol 105: 493-499. 2802. Stratton JF, Thompson D, Bobrow L, Dalal N, Gore M, Bishop DT, Scott I, Evans G, Daly P, Easton DF, Ponder BA (1999). The genetic epidemiology of early-onset epithelial ovarian cancer: a populationbased study. Am J Hum Genet 65: 1725- 1732. 2803. Straughn JM Jr., Richter HE, Conner MG, Meleth S, Barnes MN (2001). Predictors of outcome in small cell carcinoma of the cervix--a case series. Gynecol Oncol 83: 216-220. 2804. Sturgeon SR, Brinton LA, Devesa SS, Kurman RJ (1992). In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol 166: 1482-1485. 2805. Sturgeon SR, Sherman ME, Kurman RJ, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Brinton LA (1998). Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors. Cancer Epidemiol Biomarkers Prev 7: 231-235.
Page 1 and 2: References 1 . Anon. (1982). The Wo
Page 3 and 4: 1 1 4 . Aozasa K, Saeki K, Ohsawa M
Page 5 and 6: 244. Berkowitz RS, Cramer DW, Berns
Page 7 and 8: 369. Bur ME, Zimarowski MJ, Schnitt
Page 9 and 10: 501. Claus EB, Risch NJ, Thompson W
Page 11 and 12: 623. Daroca PJ Jr. (1987). Medullar
Page 13 and 14: 757. Eichhorn JH, Scully RE (1991).
Page 15 and 16: 882. Fisher RA, Lawler SD, Ormerod
Page 17 and 18: 1004. Gilks CB, Young RH, Aguirre P
Page 19 and 20: 1132. Hanselaar AG, Boss EA, Massug
Page 21 and 22: 1262. Hughesdon PE (1982). Ovarian
Page 23 and 24: 1387. Kaku T, Kamura T, Shigematsu
Page 25 and 26: 1511. Kotylo PK, Michael H, Davis T
Page 27 and 28: 1624. Lele SB, Piver MS, Barlow JJ,
Page 29 and 30: 1750. Maluf FC, Sabbatini P, Schwar
Page 31 and 32: 1870. Miller B, Flax S, Dockter M,
Page 33 and 34: 1995. Nesland JM, Lunde S, Holm R,
Page 35 and 36: 2116. Ordonez NG, Mackay B (2000).
Page 37 and 38: 2240. Phelan CM, Rebbeck TR, Weber
Page 39 and 40: 2367. Richardson WW (1956). Medulla
Page 41 and 42: 2499. Rutledge F (1967). Cancer of
Page 43: 2622. Seidman JD, Borkowski A, Aisn
Page 47 and 48: 2878. Tavassoli FA, Andradre R, Mer
Page 49 and 50: 3001. Vang R, Medeiros LJ, Silva EG
Page 51 and 52: 3125. Willemsen W, Kruitwagen R, Ba
Page 53 and 54: 3256. Zheng W, Khurana R, Farahmand

References - iarc

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?